Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine

• Published in: Parkinsonism & related disorders Vol. 23; pp. 80 - 85
• Main Authors: Broen, M.P.G, Leentjens, A.F.G, Köhler, S, Kuijf, M.L, McDonald, W.M, Richard, I.H
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2016
• Subjects: Aged; Antidepressive Agents, Second-Generation - therapeutic use; Depression; Depression - drug therapy; Depression - etiology; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurology; Parkinson Disease - psychology; Parkinson's disease; Paroxetine; Paroxetine - therapeutic use; Venlafaxine; Venlafaxine Hydrochloride - therapeutic use; Paroxetine; Depression; Venlafaxine; Parkinson's disease

Abstract Introduction Depression is considered a syndrome with a constellation of symptoms that are frequently categorized into 3 domains including affective, somatic and cognitive. There has been limited research into the domain specific magnitude or relative timing of treatment response in patient...